Abstract
Expression of human p53 carrying missense mutations at codons 175 (His175), 194 (His194), 248 (Trp248), and 273 (His273) has different effects on sensitivity of K562, 10(1), 10(3), and Rat1 cells to the antitumor drugs methotrexate, etoposide, vinblastine. These effects of mutant p53 depend on both particular amino acid substitution and cell context (histogenetic type, status of the second allele,etc.)
Similar content being viewed by others
References
C. R. Bradford, S. Zhu, G. T. Wolf,et al., Otolaryngol., Head Neck Surg.,250, 408–412 (1995).
K. Forrester, S. E. Lupold, V. L. Ott,et al., Oncogene,10, 2103–2111 (1995).
D. Harvey and A. J. Levine,Genes Dev.,5, 2375–2385 (1991).
M. Hollstein, K. Rice, M. S. Greenblatt,et al., Nucleic Acid Res.,22, 3551–3555 (1994).
L. J. Ko and C. Prives,Genes Dev.,10, 1054–1072 (1996).
B. P. Kopnin, T. P. Stromskaya, R. V. Kondratov,et al., Oncol. Res.,7, 299–306 (1995).
O. S. Kremenetskaya, N. P. Logacheva, A. Y. Baryshnikov,et al.,——Ibid.,9, 155–1666 (1997).
A. J. Levine,Cell,88, 323–331 (1997).
A. J. Levine, M. E. Perry, A. Chang,et al., Br. J. Cancer,69, 409–416 (1994).
M. Lubbert, C. W. Miller, L. Crowford, and H. P. Koeffler,J. Exp. Med.,167, 873–886 (1988).
A. Makris, T. J. Powles, M. Dowsett, and C. Allred,Lancet,345, 1181–1182 (1995).
C. Preudhomme, I. Dervite, E. Wattel,et al., J. Clin. Oncol.,13, 812–820 (1995).
V. Rusch, D. Klimstra, E. Venkatraman,et al., Cancer Res.,55, 5038–5042 (1995).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 127, No. 3, pp. 324–327, March, 1999
Rights and permissions
About this article
Cite this article
Semenyak, O.Y., Chumakov, P.M. & Kopnin, B.P. Effect on different mutant p53 on cell sensitivity to cytostatics. Bull Exp Biol Med 127, 293–295 (1999). https://doi.org/10.1007/BF02433361
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02433361